vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and BRINKER INTERNATIONAL, INC (EAT). Click either name above to swap in a different company.

BRINKER INTERNATIONAL, INC is the larger business by last-quarter revenue ($1.5B vs $749.2M, roughly 2.0× CLOVER HEALTH INVESTMENTS, CORP.). BRINKER INTERNATIONAL, INC runs the higher net margin — 8.7% vs 3.6%, a 5.1% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 3.2%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 10.3%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Brinker International, Inc. is an American multinational hospitality industry company that owns Chili's and Maggiano's Little Italy restaurant chains. Founded in 1975 and based in Dallas, Texas, Brinker currently owns, operates, or franchises 1,672 restaurants under the names Chili's Grill & Bar and Maggiano's Little Italy worldwide.

CLOV vs EAT — Head-to-Head

Bigger by revenue
EAT
EAT
2.0× larger
EAT
$1.5B
$749.2M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+58.9% gap
CLOV
62.0%
3.2%
EAT
Higher net margin
EAT
EAT
5.1% more per $
EAT
8.7%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
10.3%
EAT

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CLOV
CLOV
EAT
EAT
Revenue
$749.2M
$1.5B
Net Profit
$27.3M
$127.9M
Gross Margin
Operating Margin
3.6%
11.3%
Net Margin
3.6%
8.7%
Revenue YoY
62.0%
3.2%
Net Profit YoY
EPS (diluted)
$0.05
$2.87

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
EAT
EAT
Q1 26
$749.2M
$1.5B
Q4 25
$487.7M
$1.5B
Q3 25
$496.6M
$1.3B
Q2 25
$477.6M
$1.5B
Q1 25
$462.3M
$1.4B
Q4 24
$337.0M
$1.4B
Q3 24
$331.0M
$1.1B
Q2 24
$356.3M
$1.2B
Net Profit
CLOV
CLOV
EAT
EAT
Q1 26
$27.3M
$127.9M
Q4 25
$-49.3M
$128.5M
Q3 25
$-24.4M
$99.5M
Q2 25
$-10.6M
$107.0M
Q1 25
$-1.3M
$119.1M
Q4 24
$-22.1M
$118.5M
Q3 24
$-9.2M
$38.5M
Q2 24
$7.4M
$57.3M
Gross Margin
CLOV
CLOV
EAT
EAT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
EAT
EAT
Q1 26
3.6%
11.3%
Q4 25
-10.1%
11.6%
Q3 25
-4.9%
8.7%
Q2 25
-2.2%
9.8%
Q1 25
-0.3%
11.0%
Q4 24
-6.4%
11.5%
Q3 24
-2.7%
5.0%
Q2 24
2.0%
6.1%
Net Margin
CLOV
CLOV
EAT
EAT
Q1 26
3.6%
8.7%
Q4 25
-10.1%
8.8%
Q3 25
-4.9%
7.4%
Q2 25
-2.2%
7.3%
Q1 25
-0.3%
8.4%
Q4 24
-6.6%
8.7%
Q3 24
-2.8%
3.4%
Q2 24
2.1%
4.7%
EPS (diluted)
CLOV
CLOV
EAT
EAT
Q1 26
$0.05
$2.87
Q4 25
$2.86
Q3 25
$2.17
Q2 25
$2.31
Q1 25
$2.56
Q4 24
$2.61
Q3 24
$0.84
Q2 24
$1.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
EAT
EAT
Cash + ST InvestmentsLiquidity on hand
$177.6M
Total DebtLower is stronger
$424.4M
Stockholders' EquityBook value
$339.4M
$406.0M
Total Assets
$697.7M
$2.8B
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
EAT
EAT
Q1 26
$177.6M
Q4 25
$78.3M
$15.0M
Q3 25
$33.6M
Q2 25
$18.9M
Q1 25
$17.5M
Q4 24
$194.5M
$14.8M
Q3 24
$288.0M
$16.2M
Q2 24
$254.8M
$64.6M
Total Debt
CLOV
CLOV
EAT
EAT
Q1 26
$424.4M
Q4 25
$451.3M
Q3 25
$525.8M
Q2 25
$426.0M
Q1 25
$518.3M
Q4 24
$652.0M
Q3 24
$806.9M
Q2 24
$786.3M
Stockholders' Equity
CLOV
CLOV
EAT
EAT
Q1 26
$339.4M
$406.0M
Q4 25
$308.7M
$379.3M
Q3 25
$340.9M
$343.9M
Q2 25
$344.2M
$370.9M
Q1 25
$336.1M
$259.0M
Q4 24
$341.1M
$131.5M
Q3 24
$342.2M
$12.7M
Q2 24
$324.9M
$39.4M
Total Assets
CLOV
CLOV
EAT
EAT
Q1 26
$697.7M
$2.8B
Q4 25
$541.0M
$2.7B
Q3 25
$559.7M
$2.7B
Q2 25
$575.0M
$2.7B
Q1 25
$583.7M
$2.6B
Q4 24
$580.7M
$2.6B
Q3 24
$653.0M
$2.5B
Q2 24
$674.2M
$2.6B
Debt / Equity
CLOV
CLOV
EAT
EAT
Q1 26
1.05×
Q4 25
1.19×
Q3 25
1.53×
Q2 25
1.15×
Q1 25
2.00×
Q4 24
4.96×
Q3 24
63.54×
Q2 24
19.96×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
EAT
EAT
Operating Cash FlowLast quarter
$571.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
4.47×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
EAT
EAT
Q1 26
$571.8M
Q4 25
$-66.9M
$218.9M
Q3 25
$12.1M
$120.8M
Q2 25
$5.4M
$186.0M
Q1 25
$-16.3M
$212.0M
Q4 24
$34.8M
$218.2M
Q3 24
$50.0M
$62.8M
Q2 24
$44.8M
$141.5M
Free Cash Flow
CLOV
CLOV
EAT
EAT
Q1 26
Q4 25
$-69.0M
$155.2M
Q3 25
$11.4M
$62.2M
Q2 25
$4.8M
$106.1M
Q1 25
$-16.5M
$132.4M
Q4 24
$33.3M
$168.9M
Q3 24
$49.6M
$6.3M
Q2 24
$44.4M
$83.5M
FCF Margin
CLOV
CLOV
EAT
EAT
Q1 26
Q4 25
-14.1%
10.7%
Q3 25
2.3%
4.6%
Q2 25
1.0%
7.3%
Q1 25
-3.6%
9.3%
Q4 24
9.9%
12.4%
Q3 24
15.0%
0.6%
Q2 24
12.5%
6.9%
Capex Intensity
CLOV
CLOV
EAT
EAT
Q1 26
Q4 25
0.4%
4.4%
Q3 25
0.1%
4.3%
Q2 25
0.1%
5.5%
Q1 25
0.0%
5.6%
Q4 24
0.5%
3.6%
Q3 24
0.1%
5.0%
Q2 24
0.1%
4.8%
Cash Conversion
CLOV
CLOV
EAT
EAT
Q1 26
4.47×
Q4 25
1.70×
Q3 25
1.21×
Q2 25
1.74×
Q1 25
1.78×
Q4 24
1.84×
Q3 24
1.63×
Q2 24
6.04×
2.47×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

EAT
EAT

Company sales$1.5B99%
Franchise revenues$14.7M1%

Related Comparisons